PipelinePharma Logo

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Rosiglitazone manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

rosiglitazone + metformin

Tablets 2 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

This CTD dossier owner and manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

Manufacturer usually replies in 30 days

rosiglitazone

Tablets 2 mg, 4 mg, 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472
This company is a manufacturer and exporter of pharmaceutical products with over two decades of experience. They operate across three manufacturing facilities in India, specializing in a wide range of dosage forms including tablets, capsules, liquids, injectables, topicals, and nasal sprays. Their product portfolio encompasses generic, branded, nutraceutical, over-the-counter (OTC), and herbal medicines. Key therapy areas are not explicitly mentioned. They adhere to stringent quality standards with ISO 9001:2008 certification. The company exports its products to numerous regions globally, including the EU, North America, Africa, and the Middle East.

Manufacturer usually replies in 19 days

rosiglitazone

Tablets 4 mg, 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21324

This CTD dossier owner and manufacturer, founded in 2003 and operational since 2008, is dedicated to providing advanced pharmaceutical products across various therapeutic areas. The manufacturing facility adheres to WHO-GMP norms and international regulatory standards, specializing in tablets, capsules, and oral liquids. The company leverages state-of-the-art machinery and modern building designs within a strategically located production site accessible by road and rail. Products are distributed both domestically and internationally through a parent group that focuses on sales and promotion.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Rosiglitazone is a medication used to treat type 2 diabetes. Manufacturers of rosiglitazone use it as the standalone ingredient in drug formulations as well as in combination with other substances, such as metformin and glimepiride. Rosiglitazone suppliers market it in the form of 2mg, 4mg, and 8mg oral tablets. Alternatives to the drug include other thiazolidinedione class medications lobeglitazone and pioglitazone. The developer and earliest manufacturer of rosiglitazone was GlaxoSmithKline, who first introduced it into the market in 1999 under the trade name Avandia. Following patent expiry in 2012, other manufacturers and distributors joined the rosiglitazone market with their formulations. It is currently approved in numerous countries worldwide, including but not limited to China, Mexico, Bangladesh, and Israel. And among the largest manufacturers and suppliers of rosiglitazone in the market are companies GlaxoSmithKline, STADA, and Hengrui Pharma. Rosiglitazone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.